Advanced Enzyme Technologies Ltd — Profit & Loss Statement

₹255.30

-3.13%

Advanced Enzyme Technologies Ltd Profit & Loss Statement (Annual)

Metric	2025	2024	2023	2022
EBIT	190.92 Cr	190.75 Cr	142.81 Cr	172.85 Cr
Tax Effect Of Unusual Items	1.30 Cr	-2.42 Cr	-2.38 Cr	0.06 Cr
Tax Rate For Calcs	0.28	0.27	0.26	0.28
Normalized EBITDA	222.93 Cr	234.91 Cr	186.99 Cr	207.61 Cr
Total Unusual Items	4.55 Cr	-8.92 Cr	-9.15 Cr	0.23 Cr
Total Unusual Items Excluding Goodwill	4.55 Cr	-8.92 Cr	-9.15 Cr	0.23 Cr
Net Income From Continuing Operation Net Minority Interest	131.12 Cr	133.31 Cr	105.64 Cr	119.58 Cr
Reconciled Depreciation	36.56 Cr	35.24 Cr	35.03 Cr	34.98 Cr
Reconciled Cost Of Revenue	164.84 Cr	159.41 Cr	142.77 Cr	119.43 Cr
EBITDA	227.48 Cr	225.99 Cr	177.84 Cr	207.84 Cr
Net Interest Income	15.17 Cr	9.21 Cr	6.00 Cr	-2.55 Cr
Interest Expense	3.56 Cr	2.93 Cr	2.42 Cr	1.80 Cr
Interest Income	19.81 Cr	13.33 Cr	9.48 Cr	0.40 Cr
Normalized Income	127.86 Cr	139.81 Cr	112.41 Cr	119.42 Cr
Net Income From Continuing And Discontinued Operation	131.12 Cr	133.31 Cr	105.64 Cr	119.58 Cr
Total Expenses	475.93 Cr	450.65 Cr	402.09 Cr	360.34 Cr
Rent Expense Supplemental	7.67 Cr	7.95 Cr	6.24 Cr	4.24 Cr
Diluted Average Shares	11.20 Cr	11.19 Cr	11.18 Cr	11.19 Cr
Basic Average Shares	11.19 Cr	11.18 Cr	11.18 Cr	11.18 Cr
Diluted EPS	11.71	11.92	9.45	10.68
Basic EPS	11.72	11.92	9.45	10.70
Diluted NI Availto Com Stockholders	131.12 Cr	133.31 Cr	105.64 Cr	119.58 Cr
Net Income Common Stockholders	131.12 Cr	133.31 Cr	105.64 Cr	119.58 Cr
Otherunder Preferred Stock Dividend	0.00	0.00	0.00	0.00
Net Income	131.12 Cr	133.31 Cr	105.64 Cr	119.58 Cr
Minority Interests	-2.86 Cr	-3.65 Cr	1.77 Cr	-4.22 Cr
Net Income Including Noncontrolling Interests	133.97 Cr	136.95 Cr	103.87 Cr	123.80 Cr
Net Income Continuous Operations	133.97 Cr	136.95 Cr	103.87 Cr	123.80 Cr
Tax Provision	53.39 Cr	50.87 Cr	36.52 Cr	47.26 Cr
Pretax Income	187.36 Cr	187.82 Cr	140.39 Cr	171.06 Cr
Other Non Operating Income Expenses	6.09 Cr	14.16 Cr	3.94 Cr	4.57 Cr
Special Income Charges	-1.35 Cr	-17.53 Cr	-6.43 Cr	0.23 Cr
Other Special Charges	-0.23 Cr	15.44 Cr	4.81 Cr	-1.15 Cr
Write Off	1.58 Cr	2.10 Cr	0.93 Cr	0.92 Cr
Net Non Operating Interest Income Expense	15.17 Cr	9.21 Cr	6.00 Cr	-2.55 Cr
Total Other Finance Cost	1.08 Cr	1.19 Cr	1.06 Cr	1.16 Cr
Interest Expense Non Operating	3.56 Cr	2.93 Cr	2.42 Cr	1.80 Cr
Interest Income Non Operating	19.81 Cr	13.33 Cr	9.48 Cr	0.40 Cr
Operating Income	160.58 Cr	172.83 Cr	138.30 Cr	168.56 Cr
Operating Expense	311.09 Cr	291.24 Cr	259.32 Cr	240.91 Cr
Other Operating Expenses	81.63 Cr	79.36 Cr	75.24 Cr	61.90 Cr
Depreciation And Amortization In Income Statement	36.56 Cr	35.24 Cr	35.03 Cr	34.98 Cr
Amortization	7.56 Cr	7.74 Cr	7.30 Cr	8.00 Cr
Depreciation Income Statement	29.00 Cr	27.50 Cr	27.73 Cr	26.98 Cr
Research And Development	0.88 Cr	0.81 Cr	0.81 Cr	0.65 Cr
Selling General And Administration	42.61 Cr	39.72 Cr	37.91 Cr	35.48 Cr
Selling And Marketing Expense	21.72 Cr	15.65 Cr	16.08 Cr	14.77 Cr
General And Administrative Expense	20.89 Cr	24.07 Cr	21.83 Cr	20.72 Cr
Rent And Landing Fees	7.67 Cr	7.95 Cr	6.24 Cr	4.24 Cr
Gross Profit	471.67 Cr	464.07 Cr	397.61 Cr	409.47 Cr
Cost Of Revenue	164.84 Cr	159.41 Cr	142.77 Cr	119.43 Cr
Total Revenue	636.51 Cr	623.48 Cr	540.38 Cr	528.90 Cr
Operating Revenue	636.51 Cr	623.48 Cr	540.38 Cr	528.90 Cr
Impairment Of Capital Assets	—	0.00	0.69 Cr	0.00

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

More on Advanced Enzyme Technologies Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Biotechnology Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.